Tuberculosis caused by the intracellular bacterial pathogen Mycobacterium tuberculosis still represents a major health problem, and its effective control would best be accomplished by active vaccination. Although vaccination with M. bovis BCG has proven highly effective in certain parts of the world, in several developing countries it has been found to confer only marginal protection. Hence, novel vaccination strategies are warranted. Mycobacterium w is a saprophytic cultivable mycobacterium which shares several antigens with M. tuberculosis. In the murine system, vaccination with killed M. w was found to protect against subsequent tuberculosis. In order to characterize the responsible immune mechanisms more precisely, mice were vaccinated with killed M. w and T cells restimulated in vitro with mycobacterial antigens. These T cells produced interleukin 2 and gamma interferon but no detectable interleukin 4 and interleukin 5. Killed M. w induced significantly stronger T-cell responses than killed M. tuberculosis, and both vaccination regimes were markedly improved by administration in a mild adjuvant, i.e., the Ribi adjuvant containing trehalose dimycolate, monophosphoryl lipid A, and mycobacterial cell wall skeleton. Our data suggest that M. w-induced immunity against M. tuberculosis rests primarily on THl cells, which are thought to be of major relevance for acquired antituberculosis resistance. Our study therefore provides a further step toward the identification of a novel tuberculosis vaccine.
Globally, tuberculosis is still a major health problem. It has been estimated that annually 10 million people become diseased and 3 million people die (17, 43) . Furthermore, more than one-third of the total world population is thought to be infected with Mycobacterium tuberculosis (17) . Tuberculosis can be treated chemotherapeutically, and in several countries, vaccination with Mycobacterium bovis BCG has been remarkably successful, particularly in preventing childhood tuberculosis. Nevertheless, several field studies indicate that BCG is of low to no effectiveness in preventing tuberculosis in adults (44, (49) (50) (51) . The development of novel vaccination strategies is therefore urgently needed. This development, at the moment, follows two lines, namely, (i) construction of recombinant vaccines composed of defined antigens and carrier systems and (ii) application of killed atypical mycobacterial strains of high immunogenicity.
Mycobacterium w is a saprophytic cultivable mycobacterium which has been found to improve immunity against leprosy when given in killed form (45) . A vaccine against leprosy based on M. w is approved for human use and is currently in phase III immunotherapeutic trials, where it has resulted in clinical improvement, accelerated bacterial clearance, and increased immune responses to Mycobacterium leprae antigens (46) (47) (48) . M. w shares antigens not only with M. leprae but also with M. tuberculosis (9, 27) , and it has been found recently that vaccination with killed M. w induces protection against tuberculosis in a mouse (39) and in a guinea pig model (38a) . Here we report in vitro experiments aimed at characterizing the mechanisms underlying protective immunity caused by vaccination with killed M. w. We compared in vitro activities of T cells after vaccination * Corresponding author. 257 with killed M. w, killed M. tuberculosis, and viable BCG with or without a mild adjuvant (21) .
MATERIALS AND METHODS
Mice. C57BL/6 mice of both sexes were bred under specific-pathogen-free conditions and used at 8 to 12 weeks of age.
MAb. Rat monoclonal antibodies (MAb) against mouse gamma interferon (IFN--y) from hybridomas R4-6A2 (42) and and rat MAb against interleukin 5 (IL-5), TRFK-4, and TRFK-5 (35) were purified from culture supernatants by 50% precipitations with NH4(SO4)2 followed by affinity chromatography on protein G-Sepharose (Pharmacia, Uppsala, Sweden). R4-6A2 and TRFK-4 were extensively dialyzed against phosphate-buffered saline (PBS; pH 7.4) (Table  1) . Incorporation into Ribi adjuvant markedly increased proliferative responses in both instances. Lysates of M. w and M. tuberculosis induced stronger in vitro responses, indicating that this kind of antigen preparation facilitated the processing of these organisms. Optimum T-cell responses were observed 3 weeks after vaccination (Table 1) . Two weeks after immunization, comparable but slightly lower responses were obtained (data not shown).
Interleukin secretion by T cells from mice vaccinated with killed M. w or killed M. tuberculosis. CD4+ T cells play a crucial role in antimycobacterial immunity. For the mouse, evidence has been presented that CD4 T cells segregate into TH1 and TH2 subpopulations (23) . It is generally assumed that THl products, mainly IL-2 and IFN--y, are important for antimicrobial protection (20) , whereas the role of TH2 products, i.e., IL-4 and IL-5, is equivocal in antituberculous immunity (6) . We therefore wanted to assess which interleukins are produced after vaccination with M. w and M. tuberculosis. Mice were vaccinated and T cells were stimulated in vitro with antigens or ConA in the presence of AC. Culture supernatants were collected after 24 h and tested for IL-2, IL-4, IL-5, and IFN-y activities. T cells from mice vaccinated with M. w alone produced small but significant IL-2 activities after restimulation with M. w organisms and stronger responses after restimulation with M. w and M. tuberculosis lysates (Table 2) . Ribi adjuvant did not further increase IL-2 production by T cells from M. w-immunized mice (Table 2 ). In the M. tuberculosis-vaccinated group, measurable responses were observed only after restimulation with lysates. Immunization with M. tuberculosis in Ribi adjuvant somehow improved IL-2 production. IL-2 production was significantly lower in all groups 3 weeks after immunization.
Vaccination with M. w and restimulation with M. w, M. tuberculosis H37Ra, or M. tuberculosis H37Rv caused marked IFN--y production which was further increased after administration of M. w in Ribi adjuvant (Fig. 1) . Stronger responses were observed after restimulation with lysates than after restimulation with whole organisms. T cells from M. tuberculosis-immune mice failed to produce detectable amounts of IFN--y after restimulation with whole organism, while small but significant IFN-y activities were observed after restimulation with lysates. Following immunization with M. tuberculosis in Ribi adjuvant, IFN-y production was increased and responses to whole organisms were detectable. IFN-y production in all four immunization groups was higher 3 weeks after vaccination, in contrast to levels of IL-2, which were significantly lower at that time.
Production of IL-4 and IL-5, indicating the activation of TH2 cells, was also studied. There was no evidence for or IL-5 activities in the culture supernatants after in vitro (Tables 3 and 4) . Stronger responses were obtained when unseparated lymph node cells from BCG-immunized mice were employed, which could be explained by preferential adherence of in vivo-activated T cells to nylon wool columns (24a). IL-4 and IL-5 were not detectable after restimulation with M. w or M. tuberculosis H37Rv lysates of T cells or unseparated lymph node cells from BCG-immunized mice. Lymph node cells from M. w-immunized mice showed lower responses than purified T cells. This finding can be explained by the lower numbers of T cells in the lymph node population, because in our experiments with M. w, we found 4 x 105 T cells to be the optimum number for proliferation and lymphokine production.
Interestingly, we found high IL-5 levels after ConA stimulation of T cells and lymph node cells from BCG-immune mice, although the specific antigens failed to elicit IL-5 secretion (data not shown). In contrast, IL-4 was not detectable under these conditions. Addition of graded concentrations of rIFN-y to rIL-4 had no influence on IL-4-induced proliferation of indicator cells. This finding makes it unlikely that IL-4 was actually produced but masked by IFN--y. There was no evidence for IL-5 or IL-4 production by ConA-stimulated T cells from normal mice. DISCUSSION M. tuberculosis is an intracellular bacterium capable of replicating inside resting macrophages (10) . It is generally accepted that T cells rather than antibodies play the crucial part in resistance against tuberculosis (10) . Studies performed in murine and human systems suggest that CD4 T cells, which secrete macrophage-activating interleukins, are the major mediators of acquired resistance against tuberculosis (2, 18, 19, 21, 24, 28, 29) . Besides, CD8 T cells expressing cytolytic activities (3, 18, 24) , gamma-delta T cells (15, 26) , and natural killer cells (11, 30) Similarly, the immunogenicity of M. w was also improved after incorporation into Ribi adjuvant, as indicated by elevated IFN--y secretion after antigen restimulation. T cells from BCG-vaccinated mice produced lower IFN--y activities after restimulation than did those from M. w-vaccinated mice. This, however, may have been caused by a loss of BCG-activated T cells during in vitro purification on nylon wool columns, as observed earlier (24a) .
Increasing evidence suggests that the CD4 T-cell population can be subdivided into TH1 and TH2 cells on the basis of their interleukin secretion pattern (23) . Thus, TH1 cells primarily produce IL-2 and IFN--y, whereas TH2 cells secrete IL-4 and IL-5 as predominant factors (8, 23 THl cells is counteracted by TH2 cells and their products (13, 36, 37) . In this model, IFN--y causes protection (1, 25) against disease, whereas IL-4 leads to exacerbation (13, 22, 34, 38) . Several in vitro studies have shown that IFN--y induces tuberculostatic macrophage activities, and, by using bone marrow-derived macrophages, a major role for IFN--y in the activation of mycobacterial growth inhibition was shown (5, 19) . Using bone marrow-derived macrophages, it was also found that under certain conditions, namely, interleukin stimulation after infection, the B-cell-stimulating factors IL-4 and IL-6 also induce tuberculostasis, though to a lesser extent (6, 7) . Hence, the role of these interleukins in acquired resistance to tuberculosis remains equivocal. The finding described here that T cells from M. w-vaccinated mice produce IL-2 and IFN--y but not IL-4 and IL-5 after antigen restimulation suggests that M. w activated TH1-type T cells but left TH2 cells unaffected. Interestingly, we found significant IL-5 activities after ConA stimulation of T cells from mice immunized with BCG. Although we did not detect IL-5 activities after antigenic stimulation of these T cells, it appears that immunization with viable BCG provided a trigger for the differentiation into IL-5-producing T cells, since no IL-5 activities were observed in supernatants from ConA-stimulated normal T cells. In contrast to IL-5, IL-4 was not detected after mitogen activation of BCG-immune T cells, indicating differential expression of these two interleukins. Such a segregation has been observed in other instances (4), although coordinate expression of IL-4 and IL-5 seems to be far more common (23) .
In summary, the data presented here together with those published previously (39) suggest that M. w can induce acquired resistance to tuberculosis and that it does so by preferentially activating IFN--y-producing TH1 cells. Hence, our study provides a further step towards the rational design of improved tuberculosis vaccines.
